Toronto, Ontario--(Newsfile Corp. - February 9, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), a pioneering leader in artificial intelligence enabled health and safety technology, is pleased to announce that it has entered into an independent contractor agreement with Global Frontier Advisors L.P. ("GFA"), effective January 30, 2026. GFA will receive a combination of equity-based along with performance-based compensation during the term of the agreement, subject to applicable regulatory and exchange approvals.

Under the terms of the agreement, GFA will provide business development, engagement, and commercialization support services focused on correctional and institutional environments, industrial workforce and manufacturing settings, national security and defense entities, large-scale events and public venues, and other mutually agreed opportunities. The QAI/GFA team's effort, led by managing partner Lieutenant General Michael S. Groen (Ret.), a former Director of the U.S. Department of Defense's Joint Artificial Intelligence Center, will expand QAI's presence in international markets, addressing preemptive health surveillance concerns, broad workplace safety and wellness at-scale, subject to applicable regulatory approvals.

Dr. Rahul Kushwah, COO of QScreen AI Inc., stated: "This agreement aligns with our ongoing initiatives to strengthen our presence in key U.S. sectors where our technology can be deployed."

About Global Frontier Advisors L.P.

Global Frontier Advisors L.P. is a premier U.S.-based strategic advisory firm that facilitates access at the nexus of national security, economic resilience, and frontier market development. We identify, evaluate, and advance high-potential assets in sectors critical to U.S. and allied interests, such as critical minerals, defense technologies, artificial intelligence, renewable energy, and infrastructure. Leveraging deep operational expertise, trusted relationships across government and industry, and unmatched geopolitical insight, Global Frontier Advisors supports clients with end-to-end solutions for market entry, government relations, regulatory alignment, risk management, and capital access in some of the world's most complex environments.

About QScreenAI Inc.

QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company's Smarthealth AI stations are powered by a proprietary artificial intelligence (AI) and use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including 19 physiological vital parameters, impairment by drugs or alcohol, fatigue, or various mental illnesses. QScreen AI's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes.

Caution Regarding Forward-Looking Information:

This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any Page 4 of 4 future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the Company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.

All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.

Disclaimer: The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283141